fashion -WSS

fashion

author：hotspot 2025-09-06 03:17:20 - browse：23

Does biotech prepare you for the presidency? Who really wants to gut the FDA? And why do drug companies struggle with IT?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how Vivek Ramaswamy, fresh off his headline-grabbing debut at the first Republican presidential debate, went from a drug industry entrepreneur to a GOP rising star — and how his former biotech colleagues are reacting to it. We also explain the latest news in the life sciences, including a curious data leak and the family business of a famed biotech inventor.

For more on what we cover, here’s more on Ramaswamy; here’s the news on the data leak; here’s the story on the latest Langer venture; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Neuroscience renaissance leads to new crop of psychiatric drugs

focus

WSS

Doctor of U.S. President Joe Biden says he is fit for duty

Color Health wants to make cancer screenings convenient

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Medicare Advantage isn’t working — for anyone

Doctor of U.S. President Joe Biden says he is fit for duty

The cancer stories no one wants to hear

focus

fashion

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Medicare slashes safety net hospital payments by nearly $1 billion

Walensky prepares to leave CDC — and Congress — behind

CDC panel: People 65 and older should get a Covid spring booster shot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Personalized medicine goes far beyond genetics

Cancer drug shortages should be causing more outrage

Cholera vaccine supplies dangerously low, outbreaks surging

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Late stage cancers on the rise after pandemic delayed screenings

hotspot

Readout Newsletter: Beam, Prozac, "TechBio" and more

Neuroscience renaissance leads to new crop of psychiatric drugs

The a glaring gap in research on serious mental illness and primary care

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Alnylam reports growth in sales of rare disease treatments

Group behind ProMed defends move to subscription

hotspot

focus

focus

leisure time